Wird geladen...
Bivalirudin decreases NO bioavailability by vascular immobilization of myeloperoxidase
Bivalirudin - a direct thrombin inhibitor - has emerged as an important alternative to heparin in patients undergoing percutaneous coronary intervention. However, it remains elusive if potentially adverse extra-coagulant properties are responsible for the fact that its favorable effects in clinical...
Gespeichert in:
| Hauptverfasser: | , , , , , , , , , |
|---|---|
| Format: | Artigo |
| Sprache: | Inglês |
| Veröffentlicht: |
2008
|
| Schlagworte: | |
| Online Zugang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC2575075/ https://ncbi.nlm.nih.gov/pubmed/18701766 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1124/jpet.108.142414 |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|